Cefradine is used for the treatment of infections caused by susceptible bacteria, including acute pharyngitis, tonsillitis, otitis media, bronchitis, pneumonia, and other respiratory tract infections; urinary and genital tract infections; and skin and soft tissue infections. It is a first-generation, semi-synthetic, broad-spectrum cephalosporin antibiotic with strong activity against most Gram-positive and some Gram-negative bacteria, particularly effective against penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, and viridans group streptococci. Its clinical advantages include low incidence of adverse reactions, high safety profile, potent antibacterial activity, high stability against β-lactamases, and favorable pharmacokinetic properties.